MEDIPHARM LABS CORP (LABS.CA) Stock Price, Quote, News and Overview
TSX:LABS - Toronto Stock Exchange - CA58504D1006 - Common Stock - Currency: CAD
LABS.CA Quote, Performance and Key Statistics
TSX:LABS (8/1/2025, 7:00:00 PM)
0.065
-0.01 (-7.14%)
The current stock price of LABS.CA is 0.065 CAD.
LABS.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.51 | 2.92B | ||
| CRON.CA | CRONOS GROUP INC | 14.94 | 1.04B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 880.42M | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.63 | 783.66M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 56.09 | 614.84M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 4.81 | 572.57M | ||
| ACB.CA | AURORA CANNABIS INC | 123.4 | 347.06M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 337.86M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 24.34 | 311.80M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 247.83M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | 30.83 | 247.68M | ||
| HITI.CA | HIGH TIDE INC | N/A | 243.60M |
Related stock screener links
About LABS.CA
Company Profile
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 161 full-time employees. The company went IPO on 2018-02-09. The firm specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The company also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The company also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
Company Info
MEDIPHARM LABS CORP
151 John Street
Barrie ONTARIO L4N 2L1 CA
CEO: Patrick McCutcheon
Employees: 161
Phone: 17057197425
MEDIPHARM LABS CORP / LABS.CA FAQ
What is the stock price of MEDIPHARM LABS CORP today?
The current stock price of LABS.CA is 0.065 CAD. The price decreased by -7.14% in the last trading session.
What is the ticker symbol for MEDIPHARM LABS CORP stock?
The exchange symbol of MEDIPHARM LABS CORP is LABS and it is listed on the Toronto Stock Exchange exchange.
On which exchange is LABS.CA stock listed?
LABS.CA stock is listed on the Toronto Stock Exchange exchange.
What is MEDIPHARM LABS CORP worth?
MEDIPHARM LABS CORP (LABS.CA) has a market capitalization of 27.35M CAD. This makes LABS.CA a Nano Cap stock.
How many employees does MEDIPHARM LABS CORP have?
MEDIPHARM LABS CORP (LABS.CA) currently has 161 employees.
What are the support and resistance levels for MEDIPHARM LABS CORP (LABS.CA) stock?
MEDIPHARM LABS CORP (LABS.CA) has a support level at 0.06 and a resistance level at 0.07. Check the full technical report for a detailed analysis of LABS.CA support and resistance levels.
Is MEDIPHARM LABS CORP (LABS.CA) expected to grow?
The Revenue of MEDIPHARM LABS CORP (LABS.CA) is expected to grow by 13.35% in the next year. Check the estimates tab for more information on the LABS.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MEDIPHARM LABS CORP (LABS.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LABS.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LABS.CA, evaluating the profitability, health, valuation and growth aspects
- MEDIPHARM LABS CORP (LABS.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDIPHARM LABS CORP (LABS.CA) Sales and EPS estimates to see what analysts future expectations are.
- MEDIPHARM LABS CORP (LABS.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDIPHARM LABS CORP (LABS.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDIPHARM LABS CORP (LABS.CA) Stock Chart to make your own analysis
- MEDIPHARM LABS CORP (LABS.CA) Latest news and press-releases to stay up to date.
Does MEDIPHARM LABS CORP (LABS.CA) stock pay dividends?
LABS.CA does not pay a dividend.
When does MEDIPHARM LABS CORP (LABS.CA) report earnings?
MEDIPHARM LABS CORP (LABS.CA) will report earnings on 2025-08-18.
What is the Price/Earnings (PE) ratio of MEDIPHARM LABS CORP (LABS.CA)?
MEDIPHARM LABS CORP (LABS.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
LABS.CA Technical Analysis
LABS.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LABS.CA. LABS.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
LABS.CA Financial Highlights
Over the last trailing twelve months LABS.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 22.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -14.35% | ||
| ROE | -17.28% | ||
| Debt/Equity | 0 |
LABS.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 42% to LABS.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 74.5% and a revenue growth 13.35% for LABS.CA